Back to Search Start Over

Adverse events of intravenous immunoglobulin infusions: a three-year retrospective study in China.

Authors :
Shurong Shao
Wei Guo
Source :
Journal of Chinese Pharmaceutical Sciences. Jan2019, Vol. 28 Issue 1, p56-61. 6p.
Publication Year :
2019

Abstract

Intravenous immunoglobulin (IVIG) is biological product, which is extensively used in pediatric patients, with high adverse effects on children among different brand preparations. In the present study, we aimed to describe the adverse events of pediatric patients given IVIG infusions in China. Data were collected from all patients receiving IVIG infusion at the largest children's hospital in Ningbo of China form January 2015 to December 2017. Descriptive statistics was used. A total of 2100 patients received IVIG infusion. All the patients who experienced adverse reactions were children (0.48%), with the highest frequency of infusion among those age 1 to 3 years old (40%). Among 10 infusions with adverse reactions, the most common indication was Kawasaki disease (40%) followed by severe pneumonia (30%). Rash was the most common adverse event (80%), followed by chest pain & cough (50%) and cyanosis (40%). Adverse events were observed to occur most frequently within 30 min from onset of infusion. Most of the reactions occurred with the large dose and the indications of used for. Since the hospital changed the brand, the incidence of adverse reactions was decreased from 1.39% to 0.13%. In this study, 0.48% of pediatric patients given IVIG infusions experienced adverse events. Anaphylactoid reaction was the most common manifestation. Symptoms occurred within 30 min from onset of infusion, which were affected by the dose, the value of lgE, the indications and the different brands. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10031057
Volume :
28
Issue :
1
Database :
Academic Search Index
Journal :
Journal of Chinese Pharmaceutical Sciences
Publication Type :
Academic Journal
Accession number :
134308671
Full Text :
https://doi.org/10.5246/jcps.2019.01.007